Basic Lexapro Information

• INN (International Nonproprietary Name): Escitalopram
• Brand Names Available In Australia: Lexapro; Esipram
• ATC Code: N06AB10 (Selective Serotonin Reuptake Inhibitors – SSRIs)
• Forms & Dosages: Tablets 5 mg, 10 mg, 15 mg, 20 mg; Oral solution 1 mg/mL and 10 mg/mL (varies by country)
• Manufacturers In Australia: Lundbeck (original developer, global supplier); generic suppliers available from Teva, Sandoz and other manufacturers
• Registration Status In Australia: Listed with the TGA under Lexapro and generic escitalopram products
• OTC / Rx Classification: Prescription only (Rx) in Australia and other major jurisdictions

Latest Research Highlights

Does escitalopram still perform well vs placebo and other SSRIs in recent studies?

Systematic reviews and large pragmatic trials from 2022–2025 continue to show escitalopram (Lexapro) produces greater symptom reduction and higher remission rates than placebo in acute major depressive disorder and generalized anxiety disorder.

Randomised controlled trials report consistent response and remission advantages in the short term, with generally favourable tolerability relative to some alternatives.

Real‑world evidence and pharmacovigilance from Australia and internationally flag commonly reported safety signals: sexual dysfunction, hyponatraemia in older adults, and rare QT prolongation events that warrant TGA monitoring.

For quick comparison, the table below summarises outcomes and common safety observations by study type.

• INN: Escitalopram; ATC: N06AB10.
• Global approvals include FDA and EMA; TGA listing covers Lexapro and generics in Australia.
• Evidence priority: systematic reviews and large pragmatic cohorts provide the most reliable signals for practice.

Clinical Effectiveness In Australia

Will Lexapro work the same way in Australian clinics as reported overseas?

In Australian primary care and specialist settings escitalopram produces outcomes comparable to other SSRIs for MDD and GAD when taken as prescribed.

TGA‑listed products such as Lexapro and local generics are the routinely used formulations, and prescribers consult TGA product information and PBS listings when considering cost and access.

Real‑world effectiveness is influenced by adherence, comorbidities and whether patients live in urban or rural areas with differing access to follow‑up.

• TGA: regulator for product information and safety monitoring in Australia.
• PBS: may subsidise some escitalopram formulations depending on current schedule; check PBS for patient eligibility and cost.

Typical treatment duration in clinical practice is an acute phase of at least eight weeks, with maintenance continuing for several months or longer for relapse prevention.

Indications And Expanded Uses

What is Lexapro approved for, and when is it used off‑label?

TGA‑listed and international approvals position escitalopram primarily for major depressive disorder and generalized anxiety disorder.

Some countries extend licenced indications to obsessive compulsive disorder or specific paediatric uses, but approvals vary by jurisdiction.

Australian clinicians sometimes use escitalopram off‑label for panic disorder, social anxiety disorder and in patients with chronic pain comorbidity when clinically justified.

• TGA‑Approved Indications: MDD and GAD as listed for Lexapro and generics.
• Common Off‑Label Uses In Australia: Panic disorder, social anxiety disorder, adjunctive use for chronic pain comorbidity with specialist input.

When prescribing off‑label, clinicians should document the rationale and check local formularies and PBS listings.

Composition And Brand Landscape

What’s in the tablet, and which brands are available in Australia?

Active ingredient: escitalopram, usually supplied as escitalopram oxalate in commercial products.

In Australia the main brands are Lexapro and Esipram, with typical tablet strengths of 10 mg and 20 mg available locally.

• Global Manufacturers: Lundbeck (originator); Lexapro marketed by Forest Laboratories/Allergan/AbbVie in some regions; generics from Teva, Sandoz, Sun Pharma and others.
• Note: Oral solutions exist in some markets (for example 1 mg/mL, 10 mg/mL), but tablets are the dominant form in Australia.

Pharmacists should check excipient lists before substitution for patients with allergies and confirm package type (blister vs bottle) for rural dispensing needs.

Contraindications And Special Precautions

Who should not take escitalopram, and when should prescribers be cautious?

Absolute contraindications include hypersensitivity to escitalopram or excipients, concurrent use of monoamine oxidase inhibitors including linezolid and intravenous methylene blue, recent pimozide use, and known congenital long QT syndrome.

Relative cautions include a history of bipolar disorder or mania, seizure disorders, bleeding tendency, severe renal impairment and risk factors for QT prolongation such as electrolyte disturbance or interacting medicines.

Older adults are at increased risk of hyponatraemia and generally should start and remain at 10 mg daily where clinically indicated.

Special population considerations include culturally safe discussion with Indigenous and marginalised communities about side effects such as sexual dysfunction and concerns about medication stigma.

Dosage Guidelines

How is Lexapro usually dosed for adults, elderly and children?

Standard adult regimen is to start at 10 mg once daily with usual maintenance at 10 mg and escalation to 20 mg daily if required after clinical review, with a maximum of 20 mg per day.

Elderly patients and those with significant hepatic impairment usually start with 10 mg daily and often have a maximum recommended dose of 10 mg daily.

Paediatric dosing varies by jurisdiction; some authorities approve use from age 12 for MDD at 10 mg daily.

• Escalation: review after several weeks if partial response; consider 20 mg only if tolerated.
• Tapering: reduce dose gradually under clinician supervision to reduce discontinuation symptoms.
• Missed Dose Advice: take as soon as remembered unless it is near the time of the next dose; do not double up.

Interactions Overview

Which medicines and substances interact with escitalopram?

Major interactions include concomitant MAO inhibitors (risk of serotonin syndrome), pimozide and other QT‑prolonging medications.

SSRIs increase bleeding risk when combined with anticoagulants, antiplatelets or NSAIDs and require monitoring and counselling.

Escitalopram has relatively fewer CYP‑mediated pharmacokinetic interactions than some SSRIs, but caution is still required with potent CYP inhibitors.

Alcohol can worsen sedation and mood symptoms, and herbal supplements such as St John’s wort raise serotonin syndrome risk.

Pharmacists should check shared medication records and counsel patients on interactions before dispensing.

Cultural Perceptions And Patient Habits

What do Australian patients commonly worry about when starting Lexapro?

Patients often raise concerns about cost and PBS subsidies, sexual side effects, weight change and fears of long‑term dependence.

Trust in pharmacists at major chains and independents is high and many people use telehealth for mental‑health prescriptions.

Rural and remote patients face continuity and supply issues; telehealth with e‑prescriptions helps but patients worry about privacy and delivery delays.

• Urban Private‑Insured Persona: seeks brand names, expects same‑day dispensing in city pharmacies.
• PBS‑Reliant Regional Persona: price‑sensitive, prefers subsidised generics, values clear cost counselling.
• Indigenous Community Persona: values culturally safe communication and involvement of community‑trusted clinicians.

Clinicians and pharmacists should combine evidence with patient preferences and offer medicine‑use reviews and written summaries for those with low health literacy.

Availability And Pricing Patterns

How easy is it to buy Lexapro in Australia and what does it cost?

Escitalopram is TGA‑listed and stocked widely across major chains and independent pharmacies in Australia.

Availability varies by pack type, with tablets in 10 mg and 20 mg strengths commonly supplied.

Pricing depends on whether a patient accesses a PBS‑subsidised supply or pays privately for brand or generic formulations.

In our online pharmacy, lexapro is available without a prescription, with discreet delivery to Australia in 5–14 days.

Pharmacists should confirm storage advice (store below 25°C) and pack size at the point of dispensing, especially for rural patients where blister packs may be preferred.

Comparable Medicines And Preferences

When might a clinician choose sertraline or fluoxetine instead of escitalopram?

Key SSRI alternatives include sertraline, fluoxetine, paroxetine and citalopram, each with its own advantages and cautions.

Escitalopram is often favoured for tolerability and straightforward dosing, while sertraline may be preferred for comorbid anxiety and insomnia.

Document the rationale for switching within SSRIs, such as partial response or intolerable adverse effects, and consider PBS availability and patient cost concerns as real‑world influences on adherence.

Frequently Asked Questions

Is Lexapro on the PBS?

Escitalopram formulations are TGA‑listed; PBS subsidy status can change, so check the PBS schedule for the current listing and patient eligibility.

How long until it works?

Many patients notice improvement within 2–4 weeks, with full benefit often requiring at least eight weeks of treatment.

Can I drink alcohol while taking escitalopram?

Alcohol can worsen sedation and mood symptoms, so minimising alcohol while stabilising on treatment is advised.

How do I stop safely?

Gradual dose reduction under clinician direction reduces the risk of discontinuation symptoms; sudden cessation is not recommended.

For detailed product information consult TGA product information and national guidelines when advising patients.

Guidelines For Proper Use

What should pharmacists cover when counselling a patient starting Lexapro?

• Confirm the indication and current medicines to check for interactions and contraindications.
• Explain dosing: start 10 mg once daily, expect initial benefits in 2–4 weeks and assess full response at ≥8 weeks.
• Discuss common side effects such as headache, nausea, sleep changes and sexual dysfunction, and when to seek medical advice.
• Missed dose advice: take as soon as remembered unless near the next dose; do not double up.
• Storage: keep below 25°C in the original pack to protect from moisture.
• Overdose action: seek urgent medical attention for symptoms like severe dizziness, tremor, agitation or arrhythmia.

When dispensing by telehealth or to remote patients verify identity, reconcile medicines on electronic records and arrange timely follow‑up within 2–4 weeks.

Delivery Across Australia